Speaker

Sir Shankar Balasubramanian

Ahren Science Partner, Principal inventor of the leading next generation human genome sequencing technology core to all Illumina sequencing platforms, estimated to be worth 30BN.

About Sir Shankar

Principal inventor of the leading next generation human genome sequencing technology core to all Illumina sequencing platforms, estimated to be worth >$30BN.

Sir Shankar is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and Senior Group Leader at the Cancer Research UK Cambridge Institute. His awards include the Royal Medal (2018), the Royal Society Mullard Award (2009), The BBSRC Innovator of the year (2010) and the Tetrahedron Prize (2013). He is a Fellow of The Royal Society, the Academy of Medical Sciences and a member of
EMBO.

Topic